Andrea Tubaro

Pubblicazioni

Titolo Pubblicato in Anno
Is EMA warning on quinolones and fluoroquinolones really assessed? An EudraVigilance database analysis MINERVA UROLOGY AND NEPHROLOGY 2023
Oncological Outcomes of Patients with High-Volume mCRPC: Results from a Longitudinal Real-Life Multicenter Cohort CANCERS 2023
Statins may increase the risk of being diagnosed with prostate cancer MINERVA UROLOGY AND NEPHROLOGY 2023
Role of Perilesional Sampling of Patients Undergoing Fusion Prostate Biopsies LIFE 2023
Adverse events related to darolutamide treatment: analysis of "real life" data from EudraVigilance and the Food and Drug Administration database entries MINERVA UROLOGY AND NEPHROLOGY 2023
Adverse events related to alpha-blockers: analysis of real-life data from Eudra-Vigilance MINERVA UROLOGY AND NEPHROLOGY 2023
Comparison of Four Validated Nomograms (Memorial Sloan Kettering Cancer Center, Briganti 2012, 2017, and 2019) Predicting Lymph Node Invasion in Patients with High-Risk Prostate Cancer Candidates for Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Clinical Experience and Review of the Literature CANCERS 2023
Imaging of the Upper and Lower Urinary Tract: Radiology Textbook of Female Urology and Urogynecology: Clinical Perspectives 2023
Investigating the role of the prostate multiparametric magnetic resonance imaging sequences quality on biopsies’ outcomes EUROPEAN UROLOGY. SUPPLEMENTS 2023
Trends and incidence of reported events associated with ureteroscopes: An analysis of the food and drug administration’s manufacturer and user facility device experience database EUROPEAN UROLOGY. SUPPLEMENTS 2023
Trends and incidence of reported events associated with ureteral stents: An analysis of the food and drug administration’s manufacturer and user facility device experience database EUROPEAN UROLOGY. SUPPLEMENTS 2023
Metabolic syndrome evaluation improves prostate cancer detection in patients undergoing a repeat biopsy EUROPEAN UROLOGY. SUPPLEMENTS 2023
Trends and incidence of reported events associated with male slings: An analysis of the food and drug administration’s manufacturer and user facility device experience database EUROPEAN UROLOGY. SUPPLEMENTS 2023
NEW MINIMALLY INVASIVE TECHNIQUES VERSUS GOLDSTANDARD TREATMENT FOR MIDDLE VOLUME (30-80 ML)PROSTATES: A PROSPECTIVE RANDOMIZED STUDY THE JOURNAL OF UROLOGY 2023
DOES EARLY INTRODUCTION OF SELF INTERMITTENT CATHETERIZATION IMPROVE FUNCTIONAL OUTCOMES AND URINARY INFECTION IN ORTHOTOPIC ILEAL NEOBLADDER? RESULTS FROM A PROSPECTIVE MULTICENTRE STUDY THE JOURNAL OF UROLOGY 2023
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges CURRENT ONCOLOGY REPORTS 2023
Metabolic Syndrome and Physical Inactivity May Be Shared Etiological Agents of Prostate Cancer and Coronary Heart Diseases CANCERS 2022
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study MINERVA UROLOGY AND NEPHROLOGY 2022
The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study MINERVA UROLOGY AND NEPHROLOGY 2022
Predictive role of node-rads score in patients with prostate cancer candidates for radical prostatectomy with extended lymph node dissection: comparative analysis with validated nomograms PROSTATE CANCER AND PROSTATIC DISEASES 2022

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma